166,870 Shares in Acadia Healthcare Company Inc (ACHC) Acquired by Levin Capital Strategies L.P.

Levin Capital Strategies L.P. purchased a new stake in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) during the first quarter, Holdings Channel reports. The institutional investor purchased 166,870 shares of the company’s stock, valued at approximately $7,276,000.

A number of other hedge funds have also recently bought and sold shares of ACHC. Trellus Management Company LLC purchased a new stake in Acadia Healthcare Company during the third quarter valued at $743,000. Wells Fargo & Company MN increased its stake in Acadia Healthcare Company by 30.0% in the third quarter. Wells Fargo & Company MN now owns 6,857,782 shares of the company’s stock valued at $339,803,000 after buying an additional 1,581,959 shares during the last quarter. Rhumbline Advisers increased its stake in Acadia Healthcare Company by 4.8% in the third quarter. Rhumbline Advisers now owns 70,979 shares of the company’s stock valued at $3,517,000 after buying an additional 3,240 shares during the last quarter. Manning & Napier Advisors LLC increased its stake in Acadia Healthcare Company by 52.6% in the third quarter. Manning & Napier Advisors LLC now owns 281,040 shares of the company’s stock valued at $13,924,000 after buying an additional 96,840 shares during the last quarter. Finally, BlackRock Advisors LLC increased its stake in Acadia Healthcare Company by 4.3% in the third quarter. BlackRock Advisors LLC now owns 41,470 shares of the company’s stock valued at $2,055,000 after buying an additional 1,707 shares during the last quarter.

Institutional Ownership by Quarter for Acadia Healthcare Company (NASDAQ:ACHC)

Acadia Healthcare Company Inc (NASDAQ:ACHC) traded up 2.42% during midday trading on Friday, reaching $43.56. The company’s stock had a trading volume of 691,852 shares. Acadia Healthcare Company Inc has a 52 week low of $32.54 and a 52 week high of $63.67. The company’s 50-day moving average is $43.61 and its 200 day moving average is $40.17. The firm has a market capitalization of $3.83 billion, a P/E ratio of 253.26 and a beta of 0.91.

Acadia Healthcare Company (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, April 25th. The company reported $0.46 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.46. The firm had revenue of $679.20 million during the quarter, compared to the consensus estimate of $691.74 million. Acadia Healthcare Company had a net margin of 0.22% and a return on equity of 8.91%. The firm’s revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.55 earnings per share. Analysts expect that Acadia Healthcare Company Inc will post $2.44 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “166,870 Shares in Acadia Healthcare Company Inc (ACHC) Acquired by Levin Capital Strategies L.P.” was originally published by Mideast Time and is the sole property of of Mideast Time. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://www.mideasttime.com/166870-shares-in-acadia-healthcare-company-inc-achc-acquired-by-levin-capital-strategies-l-p/1709204.html.

Several analysts have weighed in on ACHC shares. Cantor Fitzgerald downgraded Acadia Healthcare Company from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $60.00 to $45.00 in a research note on Friday, January 27th. TheStreet raised Acadia Healthcare Company from a “d+” rating to a “c-” rating in a report on Friday, March 3rd. Zacks Investment Research cut Acadia Healthcare Company from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 31st. Citigroup Inc boosted their price objective on Acadia Healthcare Company from $43.00 to $52.00 and gave the company a “buy” rating in a report on Monday, March 6th. Finally, Mizuho reissued a “buy” rating and issued a $52.00 price objective (up previously from $45.00) on shares of Acadia Healthcare Company in a report on Monday, February 27th. Four analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $57.91.

In other news, VP Randall P. Goldberg sold 4,925 shares of Acadia Healthcare Company stock in a transaction that occurred on Thursday, May 4th. The shares were sold at an average price of $45.18, for a total transaction of $222,511.50. Following the completion of the sale, the vice president now directly owns 10,607 shares in the company, valued at approximately $479,224.26. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Ronald Morgan Fincher sold 86,483 shares of Acadia Healthcare Company stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the sale, the chief operating officer now owns 137,204 shares of the company’s stock, valued at $6,095,973.72. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 92,322 shares of company stock valued at $4,104,756. Insiders own 17.20% of the company’s stock.

Acadia Healthcare Company Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

12 Month Chart for NASDAQ:ACHC

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).

Receive News & Ratings for Acadia Healthcare Company Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.